Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.
about
Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptaseAdaptation to Human Populations Is Revealed by Within-Host Polymorphisms in HIV-1 and Hepatitis C VirusHidden drug resistant HIV to emerge in the era of universal treatment access in Southeast AsiaOptimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settingsPrevalence and impact of minority variant drug resistance mutations in primary HIV-1 infectionReappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infectionStability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance GenotypingRapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® SystemA Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingAntiviral drug resistance of human cytomegalovirus.Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesDetection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.Genotypic testing for human immunodeficiency virus type 1 drug resistance.Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.Molecular detection of antimicrobial resistanceA novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations.Accuracy of the TRUGENE HIV-1 genotyping kit.Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.Japanese external quality assessment program to standardize HIV-1 drug-resistance testing (JEQS2010 program) using in vitro transcribed RNA as reference material.Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.Evaluation of the editing process in human immunodeficiency virus type 1 genotyping.Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results.A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisResistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients.Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing.Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients.High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patientsMinor Variant Detection at Different Template Concentrations in HIV-1 Phenotypic and Genotypic Tropism Testing.Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation
P2860
Q24550959-2247955A-EF2A-471C-975D-14F09233FEFAQ27478199-1229316C-C7C6-4643-87DC-F28B6F2827FDQ28474290-9049AF41-BE56-4232-B42E-0A771EB26B49Q28478154-80780669-090C-4275-ADED-1BECC566C0B7Q28478459-CFDA7ACB-0CE5-4B29-A30E-AA8BAB13F406Q28478934-5B20C021-2E4D-402E-8CD6-A72284BC62B6Q28546274-246E714A-25EC-46EC-A87B-E9DA3D8613EFQ28551441-15A9336C-9D7A-4F50-8214-4FEB77F34223Q28552356-0700DB71-1C32-414A-A088-2DF646BCAF07Q30430427-D1032EC3-2C24-4BC3-810D-2B12EECE7393Q33686931-5359A3CD-B4E0-4C40-B04C-766D94DAF00CQ33824827-29E71582-7DED-429C-853D-CC89095B7002Q33827080-F019E6AA-05AB-41BA-B232-360F18263148Q33843999-BF1EA818-7CDA-4A93-8CB8-ACB939442373Q33906239-CC7CE0AA-F92A-4905-A65E-563E6C783BF6Q33971117-8CC08594-3705-49BE-AFD3-2532B3A9FF2EQ33972550-D0B44466-22CB-4F86-BFF5-76D4F50EAEE0Q33975793-01A524FB-F3E3-4000-947A-10C39CF1348CQ33979107-364DF01A-17FD-489C-9773-C2B1019D39ECQ34116867-DAB26CCE-D257-47FE-BAFA-32C6F41D72F8Q34454630-9DF03195-DC95-4147-9D6E-DC98D700A9FFQ34746064-437C2DD8-F065-4FF8-A56B-F4169AC41540Q34972796-76D14B12-37B0-473F-83B5-3D61C1F00775Q35056873-CB995D9B-83B8-45C3-A4F7-6FCB0696B1EEQ35141797-BFA6A931-7669-4541-86FB-95335E50B910Q35156231-4C50F3FD-87E6-4A9B-9558-6B24E3FE90D5Q35156934-A05EC04E-E0A0-488D-978C-CFA5D77E4467Q35300021-6856AB5B-1CB2-4DC0-A21E-9718CBD278A2Q35632898-F19E92FF-520A-4EF2-8D4F-C745663B9E0AQ35638409-2C41740A-9997-43B6-9915-33A5B9551BAEQ35742512-CF29D502-5425-474D-8F09-A197C558A830Q35887051-D5AFD406-48FF-40E3-B1FF-0B76AB73FEB4Q36201097-F9EFD574-55DA-4364-83EE-7536BEA93662Q36315090-E5F59958-EDDE-49F4-ACF1-9342AF094EE5Q36507279-7C576873-9ACC-4567-878F-FFD0822E5AE3Q37005868-4B41E9C7-27F5-4E7F-B147-271FB76562A9Q38370342-BD7B3C6A-D5F0-4E56-9520-CE098751DEB2Q39464193-1AEC3948-7791-4B27-A024-B09026C7FFC4Q39552923-505D4959-B839-4921-8F1D-0792EA7B9FD1Q40715404-5E728713-74AF-4778-AAD1-78FD25AE8CFF
P2860
Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Worldwide evaluation of DNA se ...... type 1 reverse transcriptase.
@ast
Worldwide evaluation of DNA se ...... type 1 reverse transcriptase.
@en
type
label
Worldwide evaluation of DNA se ...... type 1 reverse transcriptase.
@ast
Worldwide evaluation of DNA se ...... type 1 reverse transcriptase.
@en
prefLabel
Worldwide evaluation of DNA se ...... type 1 reverse transcriptase.
@ast
Worldwide evaluation of DNA se ...... type 1 reverse transcriptase.
@en
P2093
P2860
P1476
Worldwide evaluation of DNA se ...... type 1 reverse transcriptase.
@en
P2093
Reichelderfer P
Schuurman R
Tijnagel J
de Groot T
P2860
P304
P407
P577
1999-07-01T00:00:00Z